Gallagher Fiduciary Advisors’s CVS Health CVS Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$672K	Sell	6,492 -33	-0.5%	-$2.95K	0.02%	154
2026 Q1	$469K	Sell	6,525 -1,035	-14%	-$79.7K	0.02%	176
2025 Q4	$600K	Buy	7,560 +24	+0.3%	+$1.89K	0.02%	153
2025 Q3	$568K	Buy	+7,536	New	+$516K	0.02%	140
2024 Q2	–	Sell	-2,745	Closed	-$219K	–	263
2024 Q1	$219K	Buy	2,745 +16	+0.6%	+$1.22K	0.01%	177
2023 Q4	$215K	Sell	2,729 -323	-11%	-$23K	0.01%	172
2023 Q3	$213K	Buy	3,052 +31	+1%	+$2.2K	0.02%	161
2023 Q2	$209K	Sell	3,021 -258	-8%	-$18.4K	0.02%	204
2023 Q1	$244K	Buy	+3,279	New	+$275K	0.02%	175

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Gallagher Fiduciary Advisors's CVS Position: Q2 2026 in Review

Gallagher Fiduciary Advisors reduced its CVS Health (CVS) stake by 0.51% in Q2 2026, selling an estimated $2.95K and leaving 6,492 shares worth $672K. The position accounts for 0.02% of the portfolio, ranked #154.

Gallagher Fiduciary Advisors first reported a position in CVS in Q1 2023 and has held it in 9 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Gallagher Fiduciary Advisors held 6,492 shares of CVS Health worth $672K as of Q2 2026.
Gallagher Fiduciary Advisors sold 33 CVS Health shares in Q2 2026, an estimated $2.95K.
CVS Health made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #154 holding.
Gallagher Fiduciary Advisors first reported a position in CVS Health in Q1 2023 and has held it in 9 quarters since.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.